Search

Your search keyword '"Sanehito Haruyama"' showing total 9 results
Start Over Author "Sanehito Haruyama" Publisher elsevier bv
9 results on '"Sanehito Haruyama"'

1. A high expression of cell adhesion molecule 1 (CADM1) is an unfavorable prognostic factor in mycosis fungoides

Author

Emi Mashima, Sanehito Haruyama, Shun Ohmori, Manabu Yoshioka, Yu Sawada, Haruna Yoshioka, Motonobu Nakamura, Takashi Yamaguchi, and Etsuko Okada

Subjects
Male, 0301 basic medicine, Prognostic factor, Skin Neoplasms, T-Lymphocytes, Immunology, 03 medical and health sciences, Mycosis Fungoides, 0302 clinical medicine, Text mining, medicine, Humans, Immunology and Allergy, Aged, Neoplasm Staging, Aged, 80 and over, Mycosis fungoides, Chemistry, business.industry, Cell adhesion molecule, Cell Adhesion Molecule-1, Middle Aged, Prognosis, medicine.disease, Immunohistochemistry, Survival Analysis, Up-Regulation, 030104 developmental biology, 030220 oncology & carcinogenesis, Cancer research, Female, business
Published
2018
Full Text
View/download PDF

2. Drug eruption caused by memantine

Author

Motonobu Nakamura, Shun Ohmori, Ryuichi Saito, Etsuko Okada, Takashi Yamaguchi, Manabu Yoshioka, Yu Sawada, and Sanehito Haruyama

Subjects
Male, Pulmonary and Respiratory Medicine, Immunology, Pharmacology, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Memantine, medicine, Humans, Immunology and Allergy, 030212 general & internal medicine, Cholinesterase, Aged, 80 and over, biology, business.industry, medicine.disease, Drug eruption, Excitatory Amino Acid Antagonists, biology.protein, Cholinesterase Inhibitors, Drug Eruptions, business, medicine.drug
Published
2017
Full Text
View/download PDF

4. Expression of activation induced deaminase (AID) and BRAF V600E mutation in malignant melanoma

Author

Kana Hiromasa, Haruna Yoshioka, Yumiko Sakuragi, Takashi Yamaguchi, Natsuko Saito, Manabu Yoshioka, Daisuke Nishio, Sanehito Haruyama, Reiko Watabe, Rieko Kubo, Emi Mashima, Daisuke Omoto, and Motonobu Nakamura

Subjects
Melanoma, Mutation (genetic algorithm), medicine, Cancer research, Activation-induced (cytidine) deaminase, biology.protein, Dermatology, Biology, medicine.disease, Molecular Biology, Biochemistry
Published
2016
Full Text
View/download PDF

5. Multiple fixed drug eruption caused by ropinirole in a patient with Parkinson's disease

Author

Daisuke Nishio, Sanehito Haruyama, Natsuko Sasaki-Saito, Manabu Yoshioka, Daisuke Omoto, Motonobu Nakamura, Shun Ohmori, and Yu Sawada

Subjects
lcsh:Immunologic diseases. Allergy, medicine.medical_specialty, Parkinson's disease, Pars compacta, business.industry, Dopaminergic, 030209 endocrinology & metabolism, Substantia nigra, Pigmentations, General Medicine, medicine.disease, Dermatology, Drug eruption, 03 medical and health sciences, 0302 clinical medicine, Ropinirole, Dopamine receptor D2, medicine, Immunology and Allergy, business, lcsh:RC581-607, 030217 neurology & neurosurgery, medicine.drug
Abstract

Parkinson's disease is derived from a degeneration of the dopaminergic neurons in the substantia nigra pars compacta, which leads to a marked loss of striatal dopamine concentration. Among the treatment for Parkinson's disease, the number of patients taking dopamine D2 receptor agonist is on the rise. Ropinirole, a selective dopamine D2 receptor agonist, shows a strong inhibitory effect on the pathogenesis of Parkinson's disease. 1 Although several adverse events of ropinirole are well-known, such as sleep disturbance, a drug eruption due to ropinirole has not been reported in English so far. Herein, we describe here an unusual case of a patient with Parkinson's disease who developed multiple fixed drug eruption after ropinirole treatment. We also reviewed the past literature on drug eruption caused by other dopamine D2 receptor agonists further. A 60-year-old female with Parkinson's disease was referred to our department for evaluation of an eruption of 2 days' duration. An erythematous eruption on the extremities had developed three hours after 7th daily administration of ropinirole for her Parkinson's disease. The erythematous lesions gradually became pigmented. On physical examination, well-defined pigmentations

Published
2016
Full Text
View/download PDF

6. Maculopapular type drug eruption caused by silodosin

Author

Daisuke Omoto, Motonobu Nakamura, Manabu Yoshioka, Yu Sawada, Shun Ohmori, Daisuke Nisio, Akiha Inoue, and Sanehito Haruyama

Subjects
lcsh:Immunologic diseases. Allergy, medicine.medical_specialty, business.industry, Treatment outcome, 030232 urology & nephrology, General Medicine, Silodosin, medicine.disease, Dermatology, Drug eruption, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, medicine, Immunology and Allergy, Skin pathology, business, lcsh:RC581-607, medicine.drug
Published
2016
Full Text
View/download PDF

7. 575 High expression of cell adhesion molecule 1 is a predictive unfavorable prognostic factor in patients with mycosis fungoides

Author

Takashi Yamaguchi, Yu Sawada, Shun Ohmori, Motonobu Nakamura, Sanehito Haruyama, H. Yoshika, Emi Mashima, Manabu Yoshioka, and Etsuko Okada

Subjects
Mycosis fungoides, Prognostic factor, business.industry, Cell adhesion molecule, Cancer research, Medicine, In patient, Cell Biology, Dermatology, business, medicine.disease, Molecular Biology, Biochemistry
Published
2017
Full Text
View/download PDF

8. 422 Galectin-7 suppresses the erythema and cytokine productions in Nc/Nga mice, an atopic dermatitis model

Author

Yu Sawada, Emi Mashima, Motonobu Nakamura, Manabu Yoshioka, Takashi Yamaguchi, Etsuko Okada, R. Kubo, and Sanehito Haruyama

Subjects
Erythema, business.industry, medicine.medical_treatment, Cell Biology, Dermatology, Atopic dermatitis, medicine.disease, Biochemistry, Cytokine, Immunology, medicine, medicine.symptom, business, Molecular Biology, Galectin
Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results